ATE85215T1 - Antivirales therapeutikum. - Google Patents

Antivirales therapeutikum.

Info

Publication number
ATE85215T1
ATE85215T1 AT88901147T AT88901147T ATE85215T1 AT E85215 T1 ATE85215 T1 AT E85215T1 AT 88901147 T AT88901147 T AT 88901147T AT 88901147 T AT88901147 T AT 88901147T AT E85215 T1 ATE85215 T1 AT E85215T1
Authority
AT
Austria
Prior art keywords
liposome
protein
antiviral therapeutic
envelope
engulf
Prior art date
Application number
AT88901147T
Other languages
English (en)
Inventor
Slobodan Tepic
Original Assignee
Experimentelle Chirurgie Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Experimentelle Chirurgie Lab filed Critical Experimentelle Chirurgie Lab
Application granted granted Critical
Publication of ATE85215T1 publication Critical patent/ATE85215T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88901147T 1987-12-19 1987-12-19 Antivirales therapeutikum. ATE85215T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88901147A EP0346343B1 (de) 1987-12-19 1987-12-19 Antivirales therapeutikum
PCT/EP1987/000806 WO1989005633A1 (en) 1987-12-19 1987-12-19 Anti-viral therapeutic composition

Publications (1)

Publication Number Publication Date
ATE85215T1 true ATE85215T1 (de) 1993-02-15

Family

ID=8165225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88901147T ATE85215T1 (de) 1987-12-19 1987-12-19 Antivirales therapeutikum.

Country Status (5)

Country Link
EP (1) EP0346343B1 (de)
JP (1) JPH02502633A (de)
AT (1) ATE85215T1 (de)
DE (1) DE3784080T2 (de)
WO (1) WO1989005633A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US5026557A (en) * 1987-09-09 1991-06-25 The Liposome Company, Inc. Adjuvant composition
EP0432693A1 (de) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Für virusinfizierte Zellen cytotoxische Liposomen
WO2014116723A1 (en) * 2013-01-22 2014-07-31 The Charles Stark Draper Laboratory, Inc. Multivalent liposome formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
DE2942780A1 (de) * 1979-10-23 1981-05-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Eukaryotische zellen, eukaryotische protoplasten und vielzellige eukaryotische lebende organismen mit einem gehalt an durch lipidvesikel eingebrachter dna, verfahren zu ihrer herstellung von gen-produkten, zur immunisierung und zur behebung genetisch bedingter defekte
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
US4652257A (en) * 1985-03-21 1987-03-24 The United States Of America As Represented By The Secretary Of The Navy Magnetically-localizable, polymerized lipid vesicles and method of disrupting same
US4663161A (en) * 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
JPS63501716A (ja) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用
FR2592893A1 (fr) * 1986-01-15 1987-07-17 Pasteur Institut Population de lymphocytes t4 specifiques du virus lav, leur procede d'obtention et leur application a la production de ce virus.

Also Published As

Publication number Publication date
EP0346343A1 (de) 1989-12-20
JPH02502633A (ja) 1990-08-23
WO1989005633A1 (en) 1989-06-29
DE3784080T2 (de) 1993-05-27
EP0346343B1 (de) 1993-02-03
DE3784080D1 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
ES550452A0 (es) Perfeccionamientos en la fabricacion de prendas de un solo uso,con aberturas reforzadas y elasticas
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
AU3332089A (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
NZ217645A (en) Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations
KR870700638A (ko) 임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도
EP0491844A4 (en) Peptides including ctl epitopes of hiv proteins and use thereof
FI912784A7 (fi) Porfyriinien valmistus ja käyttö
GB2190382B (en) "enhanced expression of human interleukin-2 or analogues in mammalian cells.
AU4638085A (en) Therepautic preparations fortreatment of certain viral and other diseases and the preparation of the same
ATE85215T1 (de) Antivirales therapeutikum.
IT8619072A0 (it) Miglioramenti relativi a preparati virali di isolamento e al loro uso.
IT1214598B (it) Uso terapeutico della fosfocreatina.
NO171242C (no) Fremgangsmaate for fremstilling av hudpleiepreparater med keratolytisk og antiinflammatorisk virkning
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
DK141090A (da) Fremstilling af human prourokinase
NZ224393A (en) Recombinant hiv envelope proteins and uses thereof
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
FI881123A7 (fi) Human Immunodeficiency Viruksen (HIV) inaktivoiminen proteiinipitoisissa liuoksissa fenolilla.
ES542349A0 (es) "procedimiento para separar y obtener d-alfa-tocoferol"
ATE336588T1 (de) In-vitro verpackung von adeno-assozierten virus dns
ZA893085B (en) Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU6840487A (en) Plasmid and phage clones of human T-cell lymphotropic virus type III
NO912099D0 (no) Ekspresjon av hiv-proteiner i drosophilia-celler.
FR2622108B1 (fr) Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
FI896050A7 (fi) 5-asyyliamino-1,2,4-triatsoli-3-sulfoniamidien ja välituotteiden valmistus

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee